Evidence map›Paper›PMID 24747115›Full record

ArticleAtherosclerosis2014

Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.

Chuchun L Chang, Claudia Torrejon, Un Ju Jung, Kristin Graf, Richard J Deckelbaum

Open access · bronzeAbstract read
In one paragraph

Article in Atherosclerosis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Nutrigenomics of Dietary Lipids.Antioxidants (Basel, Switzerland) · 2021
    Review
  4. Review
  5. Lipoprotein lipase: new roles for an 'old' enzyme.Current opinion in clinical nutrition and metabolic care · 2019
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Chuchun L ChangInstitute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Claudia TorrejonInstitute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Campus Norte Hospital Roberto del Río, University of Chile, Santiago, Chile.
Un Ju JungInstitute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Kristin GrafCampus Norte Hospital Roberto del Río, University of Chile, Santiago, Chile.
Richard J DeckelbaumInstitute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY, USA. Electronic address: rjd20@columbia.edu.
Columbia University · USHospital Roberto del Rio · CL

Funding

POSTDOCTORAL TRAINING IN ARTERIOSCLEROSIS RESEARCHT32HL007343 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HENRY N GINSBERG, Muredach P Reilly · 1985 to 2026
$12.7M
NUTRITIONT32DK007647 · NIDDK · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anthony W Ferrante, Lori M Zeltser · 1990 to 2026
$7.4M
METABOLISM OF INTRAVENOUS LIPID EMULSIONSR01HL040404 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DECKELBAUM, RICHARD JOSEPH · 1988 to 2008
$2.9M
NHLBI NIH HHS HL007343NHLBI NIH HHS HL40404NHLBI NIH HHS R01 HL040404NHLBI NIH HHS T32 HL007343NIDDK NIH HHS T32 DK007647
6 · The paper itself

Abstract

objectiveEffects of progressive substitution of dietary n-3 fatty acids (FA) for saturated FA (SAT) on modulating risk factors for atherosclerosis have not been fully defined. Our previous reports demonstrate that SAT increased, but n-3 FA decreased, arterial lipoprotein lipase (LpL) levels and arterial LDL-cholesterol deposition early in atherogenesis. We now questioned whether incremental increases in dietary n-3 FA can counteract SAT-induced pro-atherogenic effects in atherosclerosis-prone LDL-receptor knockout (LDLR-/-) mice and have identified contributing mechanisms. METHODS AND

resultsMice were fed chow or high-fat diets enriched in SAT, n-3, or a combination of both SAT and n-3 in ratios of 3:1 (S:n-3 3:1) or 1:1 (S:n-3 1:1). Each diet resulted in the expected changes in fatty acid composition in blood and aorta for each feeding group. SAT-fed mice became hyperlipidemic. By contrast, n-3 inclusion decreased plasma lipid levels, especially cholesterol. Arterial LpL and macrophage levels were increased over 2-fold in SAT-fed mice but these were decreased with incremental replacement with n-3 FA. n-3 FA partial inclusion markedly decreased expression of pro-inflammatory markers (CD68, IL-6, and VCAM-1) in aorta. SAT diets accelerated advanced atherosclerotic lesion development, whereas all n-3 FA-containing diets markedly slowed atherosclerotic progression.

conclusionMechanisms whereby dietary n-3 FA may improve adverse cardiovascular effects of high-SAT, high-fat diets include improving plasma lipid profiles, increasing amounts of n-3 FA in plasma and the arterial wall. Even low levels of replacement of SAT by n-3 FA effectively reduce arterial lipid deposition by decreasing aortic LpL, macrophages and pro-inflammatory markers.

Indexed as

Cholesterol, DietaryDiet, High-FatAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticAortaAortic DiseasesAtherosclerosisBody WeightCD68 MoleculeDisease Models, AnimalDown-RegulationFish OilsInflammation MediatorsInterleukin-6LipidsAntigens, CDAntigens, Differentiation, MyelomonocyticCD68 MoleculeCD68 protein, mouseCholesterol, DietaryFish OilsInflammation MediatorsInterleukin-6interleukin-6, mouseLipidsLipoprotein LipaseMenhaden oilReceptors, LDLVascular Cell Adhesion Molecule-1AtherosclerosisInflammationLDLR−/−Lipoprotein lipasen−3 fatty acids

Identifiers

PMID24747115
PMCPMC4075280
OpenAlexW2150258000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.